Safety and Efficacy of Blinatumomab in Adults With Newly Diagnosed High-risk Diffuse Large B-Cell Lymphoma
Clinical trial NCT03023878 · COMPLETED
Trial details
- NCT number
- NCT03023878
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-13
- Primary completion
- 2019-04-04
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.